MedPath

HDR Curve for Heparin Dose Determination in pediatric patients undergoing cardiac surgery

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/08/072588
Lead Sponsor
AIIMS NEW DELHI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Pediatric cardiac surgical patients less than 14 years old posted for elective cardiac surgery on cardiopulmonary bypass.

Exclusion Criteria

Patients who refuse to participate in the study

Emergency surgery

Redo surgery

Patients with allergy to Heparin or Protamine

Renal dysfunction

Severe liver disease

CPB time more than 180 minutes

Patients on preoperative anticoagulants

Patients greater than 14 years of age

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To ascertain whether or not heparin dose administered as determined by HDR curve achieves target ACT of 480 before CPB.Timepoint: Before going on bypass.
Secondary Outcome Measures
NameTimeMethod
To compare total dose of heparin given in both the groups. <br/ ><br>To compare protamine dose administered in both the groups. <br/ ><br>To compare amount of postoperative blood loss between the study groups. <br/ ><br>Timepoint: Intraoperative and post operative
© Copyright 2025. All Rights Reserved by MedPath